ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

HBIO Harvard Bioscience Inc

3.92
0.07 (1.82%)
Última actualización: 14:40:42
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Harvard Bioscience Inc HBIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.07 1.82% 3.92 14:40:42
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.91 3.90 4.08 3.85
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202407:45GLOBEHarvard Bioscience Schedules First Quarter 2024 Earnings..
09/4/202408:00GLOBEHarvard Bioscience Announces Action to Improve Operational..
11/3/202407:00GLOBEHarvard Bioscience, Inc. to Participate in March 2024..
07/3/202416:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202406:00EDGAR2Form 8-K - Current report
07/3/202406:00GLOBEHarvard Bioscience Announces Fourth Quarter 2023 Financial..
06/3/202407:30GLOBEHarvard Bioscience to Showcase Latest Solutions for..
27/2/202416:10GLOBEHarvard Bioscience Schedules Fourth Quarter 2023 Earnings..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202416:01EDGAR2Form 8-K - Current report
03/1/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:40GLOBEHarvard Bioscience to Present at Benchmark Company’s..
09/11/202315:30GLOBEHarvard Bioscience to Present at Southwest IDEAS Investor..
07/11/202315:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:00EDGAR2Form 8-K - Current report
07/11/202306:00GLOBEHarvard Bioscience Announces Third Quarter 2023 Financial..
06/11/202315:30GLOBEHarvard Bioscience to Showcase Latest Innovations in..
30/10/202308:00GLOBEHarvard Bioscience Schedules Third Quarter 2023 Earnings..
18/9/202307:57GLOBEHarvard Bioscience and Etisense Announce Agreement for..
21/8/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202308:05EDGAR2Form 8-K - Current report
08/8/202306:18GLOBEHarvard Bioscience Announces Second Quarter 2023 Financial..
03/8/202317:30GLOBEHarvard Bioscience to Present at Sidoti Virtual Investor..
27/7/202317:36GLOBEHarvard Bioscience Schedules Second Quarter 2023 Earnings..
22/6/202306:55GLOBEHarvard Bioscience Set to Join Russell 2000® and 3000®..
20/6/202307:01GLOBEHarvard Bioscience Appoints Jennifer Cote as Chief Financial..

Su Consulta Reciente

Delayed Upgrade Clock